The impact of morbid events on survival following hospitalization for complicated myocardial infarction

被引:8
作者
Dickstein, K [1 ]
Gleim, GW
Snapinn, S
James, MK
Kjekshus, J
机构
[1] Univ Bergen, Stavanger Univ Hosp, Div Cardiol, N-4011 Stavanger, Norway
[2] Merck Res Labs, West Point, PA USA
[3] Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway
关键词
myocardial infarction; morbidity; mortality; hospitalization;
D O I
10.1016/j.ejheart.2005.04.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Little is known about the importance of morbid events with respect to longer term survival following MI hospital discharge. Aims: Establish the risk of death associated with morbid events following initial discharge from MI hospitalization. Methods: We examined the rates of morbid events (reinfarction, stroke/TIA, revascularization, heart failure (HF) hospitalization, cardiovascular hospitalization and all-cause hospitalization) and the relationships of these events to subsequent death in patients who survived the initial hospitalization for MI (n =5301) in the OPTIMAAL trial. Events were classified as Early (30 days post discharge) and Late (> 30 days post discharge) for an average of 2.7 years follow-up. Results: Death rates were higher in the Early period (0.20 deaths/patient year) than in the Late period (0.05 deaths/patient year). Once a morbid event, excluding revascularization, occurred, the acute hazard ratios (HR, determined by Cox regression) for death on the day of event were higher than at time periods following the event and were highest for reinfarction and stroke/TIA. The acute HRs for death for all 6 morbid events were especially high for events occurring during the Late period. The highest chronic HR for death was associated with HF and all-cause hospitalizations. By contrast, the chronic HR for death from revascularization in both the Early (HR=0.3) and Late (HR=0.4) period indicated reduced risk. Conclusions: The results document event rates following hospitalization for MI, provide quantification of the associated risk for death, and may be useful in designing clinical trials. The serious morbid events examined may serve as potential surrogate endpoints in long-term studies and identify patients that should be targeted for aggressive management. (c) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:74 / 80
页数:7
相关论文
共 15 条
[1]  
*AM HEART ASS, 2002, HEART DIS STROK STAT
[2]   Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial [J].
Dickstein, K ;
Kjekshus, J .
LANCET, 2002, 360 (9335) :752-760
[3]   Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction:: The OPTIMAAL trial design [J].
Dickstein, K ;
Kjekshus, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (04) :477-481
[4]   Comparison of baseline data, initial course, and management:: Losartan versus captopril following acute myocardial infarction (The OPTIMAAL trial) [J].
Dickstein, K ;
Kjekshus, J .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (06) :766-+
[5]   A validated prediction model for all forms of acute coronary syndrome - Estimating the risk of 6-month postdischarge death in an international registry [J].
Eagle, KA ;
Lim, MJ ;
Dabbous, OH ;
Pieper, KS ;
Goldberg, RJ ;
Van de Werf, F ;
Goodman, SG ;
Granger, CB ;
Steg, PG ;
Gore, JM ;
Budaj, A ;
Avezum, A ;
Flather, MD ;
Fox, KAA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (22) :2727-2733
[6]   CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION IN RELATION TO OCCURRENCE OF CONGESTIVE-HEART-FAILURE [J].
EMANUELSSON, H ;
KARLSON, BW ;
HERLITZ, J .
EUROPEAN HEART JOURNAL, 1994, 15 (06) :761-768
[7]   Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: A multi-hospital community-wide perspective [J].
Furman, MI ;
Dauerman, HL ;
Goldberg, RJ ;
Yarzbeski, J ;
Lessard, D ;
Gore, JM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (06) :1571-1580
[8]   The independent effects of left ventricular ejection fraction on short-term outcomes and resource utilization following hospitalization for heart failure [J].
Harjai, K ;
Nunez, E ;
Turgut, T ;
Shah, MP ;
Humphrey, JS ;
Newman, J ;
Cheirif, J ;
Smart, FW ;
Ventura, HO .
CLINICAL CARDIOLOGY, 1999, 22 (03) :184-190
[9]   Frequency, patient characteristics, and, outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: Lessons from 4 international fibrinolytic therapy trials [J].
Hasdai, D ;
Topol, EJ ;
Kilaru, R ;
Battler, A ;
Harrington, RA ;
Vahanian, A ;
Ohman, EM ;
Granger, CB ;
Van de Werf, F ;
Simoons, ML ;
O'Connor, CM ;
Holmes, DR .
AMERICAN HEART JOURNAL, 2003, 145 (01) :73-79
[10]  
Hennen J, 1995, Conn Med, V59, P263